Byung-wan W. Lee

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 181 publications

Lower glucagon response and attenuated hepatic glucagon signaling in MASLD.

Lower glucagon response and attenuated hepatic glucagon signaling in MASLD.

Journal: Diabetes & metabolism

Published: June 17, 2026

Intermittent Fasting and Risk of Diabetic Retinopathy: Retrospective Data from the National Health and Nutrition Examination Survey.

Intermittent Fasting and Risk of Diabetic Retinopathy: Retrospective Data from the National Health and Nutrition Examination Survey.

Journal: Nutrients

Published: May 04, 2026

Contemporary Type 2 Diabetes Guidelines: Converging Evidence, Diverging Strategies, and the Position of the Korean Diabetes Association Framework.

Contemporary Type 2 Diabetes Guidelines: Converging Evidence, Diverging Strategies, and the Position of the Korean Diabetes Association Framework.

Journal: Endocrinology and metabolism (Seoul, Korea)

Published: April 07, 2026

Circulating β-Hydroxybutyrate in Glycemic Progression and Diabetic Cardiomyopathy: Adaptive Signal or Maladaptive Substrate?

Circulating β-Hydroxybutyrate in Glycemic Progression and Diabetic Cardiomyopathy: Adaptive Signal or Maladaptive Substrate?

Journal: International journal of molecular sciences

Published: March 20, 2026

Hyperoxia-induced fatty liver injury through the AKT-dependent and HIF-2α-independent pathways.

Hyperoxia-induced fatty liver injury through the AKT-dependent and HIF-2α-independent pathways.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: March 18, 2026

Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real-World Observational Study.

Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real-World Observational Study.

Journal: Diabetes, obesity & metabolism

Published: January 15, 2026

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial.

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial.

Journal: Diabetes, obesity & metabolism

Published: December 16, 2025

Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes.

Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes.

Journal: Diabetes & metabolism journal

Published: October 01, 2025

In-silico biomechanical simulation of tendon transfers for finger extension in radial nerve palsy.

In-silico biomechanical simulation of tendon transfers for finger extension in radial nerve palsy.

Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS

Published: August 22, 2025

The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes.

The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes.

Journal: International journal of molecular sciences

Published: July 20, 2025

Efficacy and Safety of HD-6277, a Novel G Protein-Coupled Receptor 40 Agonist, in Individuals with Type 2 Diabetes Mellitus: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Clinical Trial.

Efficacy and Safety of HD-6277, a Novel G Protein-Coupled Receptor 40 Agonist, in Individuals with Type 2 Diabetes Mellitus: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Clinical Trial.

Journal: Diabetes & metabolism journal

Published: July 17, 2025

Metabolic Dysfunction-Associated Steatotic Liver Disease and Low Handgrip Strength Are Associated with a Higher Risk of Cardiovascular Disease.

Metabolic Dysfunction-Associated Steatotic Liver Disease and Low Handgrip Strength Are Associated with a Higher Risk of Cardiovascular Disease.

Journal: Journal of obesity & metabolic syndrome

Published: June 20, 2025

Showing 1-12 of 181

Last Updated: 09/26/2026